ctrl K

AI Score

Unlock

Lyell Immunopharma Inc. (LYEL)

AI Score

Unlock

0.66

-0.05 (-7.15%)

At close: Mar 03, 2025, 3:59 PM

0.66

-0.15%

After-hours: Mar 03, 2025, 04:00 PM EST

Lyell Immunopharma Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Cash & Equivalents	145.65M	123.55M	293.83M	140.41M	96.67M
Short-Term Investments	400.58M	516.6M	320.97M	472.21M	339.38M
Long-Term Investments	48.51M	115.04M	330.53M	163.44M	68.98M
Other Long-Term Assets	4.52M	4.96M	3.95M	3.23M	2.68M
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.46M	11.14M	22.98M	4.93M	8.42M
Total Current Assets	554.69M	651.29M	626.29M	617.55M	440.26M
Property-Plant & Equipment	142.32M	166.26M	166.64M	124.06M	43.7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	195.34M	286.27M	501.12M	290.73M	115.37M
Total Assets	750.03M	937.56M	1.13B	908.28M	555.63M
Account Payables	4.82M	3.92M	3.21M	9.4M	2.84M
Deferred Revenue	n/a	21.87M	4.99M	6.09M	4.51M
Short-Term Debt	6.27M	4.53M	1.17M	3.62M	344K
Other Current Liabilities	23.43M	28.58M	37.37M	30.18M	14.35M
Total Current Liabilities	34.52M	37.03M	46.74M	49.28M	22.05M
Long-Term Debt	56.89M	126.34M	133.3M	50.96M	27.13M
Other Long-Term Liabilities	3.66M	-59.05M	-62.08M	532K	n/a
Total Long-Term Liabilities	60.56M	67.28M	150.88M	140.56M	125.53M
Total Liabilities	95.08M	104.31M	197.62M	189.84M	147.58M
Total Debt	63.17M	67.7M	67.82M	54.57M	27.47M
Common Stock	25K	25K	24K	2K	1K
Retained Earnings	-1B	-767.48M	-584.36M	-334.14M	-129.67M
Comprehensive Income	-94K	-7.6M	-1.62M	256K	454K
Shareholders Equity	654.95M	833.25M	929.79M	718.44M	408.06M
Total Investments	449.08M	631.64M	651.5M	635.66M	408.36M